Medical Marijuana's effects on Parkinson's

Please watch this very short clip.



Watch Medical Marijuana's effect on Parkinson's, Part 3 of 3. Aided by a fellow Parkinson's patient and marijuana advocate, Larry tries medical marijuana for the first time. With a few drops of cannabis oil under his tongue, Larry's severe dyskinesia (uncontrolled movements), loss of voice, and tremors are calmed within in minutes! We didn't even edit the footage because the results were so startling. Please share this to help educate the public. This isn't about politics, people need to see how medical marijuana works on very real patients with very real problems!


I have seen the effects of cannabis on seizures, Parkinson's, PTSD and cancer.

Cannabis does not nor should it need to be monetized or monopolized by the government on behalf of pharmaceutical companies. Not by your govt or any govt. Cannabis belongs in the public domain.
Why? Because the human body arrives delivered with an immature nervous system and a mature cannabinoid receptor pathway built in.

When you buy a computer it comes with a full operating system built in and you don't expect to have to license and gain approval for a component to enable the proper functioning of your computer after delivery to your home, do you? No. Well now, the body is your fully functioning operating self modulating machine and cannabis ( oil and fresh juice) is integral to its high speed performance value. It's not the wifi, it's the code enabling function modulator.
   
The US govt has given the patent rights to Big Pharma while the FDA has now rewritten the cannabis scheduling laws to include the extracts of cannabis on its Scheduke 1 list. The FDA does not have subject matter jurisdiction to write or pass laws or amend laws to include previously unlisted components without due process and public input.

The FDA under the Dept of Human Resources is a Racketeering and Criminal Enterprise, engaging in collusion with Criminal Intent to Influct Criminal Abuse Criminal Harm and by Malice protect Special Interests in violation of its corporate mandates to serve the public health and to regulate for purposes of safety.

  As such the FDA is a criminal violator of Public Trust.

You think about that.

You think about the reach of the FDA and its serial complicity against Public Health, Wellness and its collusion with principals and agents above and below its authority.

You think about the many thousands of victims caught in the crosshairs of the FDAs over reach and criminal protection racket.

 You think about the victims of legislature enforced to protect that criminal protection racket
You think about the cronyism of the private for profit prison system benefitting from the cronyism of that criminal protection racket.

You watch this clip and think of the hundreds of thousands, millions of people suffering from seizure disorders, PTSD, cancer and many associative disorders and illness who are unable to access cannabis oil and fresh juice because of the criminal cronyist racketeering of the FDA and you remember that the govt of the US has owned the patents and research knowledge of this in full measure since before the first patent application on behalf of the US govt in 1974.

42 years.... Of racketeering and collusion to deny human benefits to something so simple.
42 years.....Of racketeering and collusion to feed a private for profit prison system.
42 years is a lifetime. It's more time than many needy patients were granted under this system of predatory corporate racketeering and collusion to protect special interests instead of human interest.
Patient Right to Access.
42 years is 42 years too long.

For those who are jumping on the bandwagon of rhetoric regarding cannabis medical approval by states... Save it. Your ignorance is astounding. GMO cannabis is no different to GMO corn, sugar beets, pineapples, potatoes, rice, soybeans and rape seed.
    
There is not a pharmaceutical on the market whose original benefits were not derived from the Botanical World. Synthetic derivatives are not the original compound and do not offer the same benefits. On the contrary synthetics come with risk benefit ratios you are not informed of but bear the burden of.

There is no informed consent to treatments. None.


Now please watch the clip.
DES.

PTSD

U.S.: Marijuana Cannabinoids Could Point The Way To First Effective Medication For PTSD - (Post Traumatic Stress Disorder)

  

In a first-of-its-kind study on the biochemical impact of psychological trauma, researchers have discovered a connection between the amount of cannabinoid receptors in the human brain and the chronic, disabling condition post-traumatic stress disorder (PTSD).

The findings, from New York University Langone Medical Center, appeared online Tuesday in the journal Molecular Psychiatry, reports Science Daily. They will also be presented this week at the annual meeting of the Society of Biological Psychiatry in San Francisco.

There are a number of treatments using psychotherapy and cognitive behavioral therapy for PTSD patients, but these methods aren't always available, reports Loren Grush at Fox News.

No pharmaceutical treatments have yet been developed to specifically target PTSD.

The NYU Langone Center researchers utilized brain imaging technology to highlight the connection between the number of cannabinoid receptors in the brain and PTSD. The cannabinoid receptors, known as CB1 receptors, are activated in the brain when a person uses marijuana, which can lead to impaired short-term memory and reduced anxiety.

CB1 receptors are part of the body's natural endocannabinoid system, a network of chemicals and signaling pathways in the body which plays a role in memory formation, appetite, pain tolerance and mood. Animal studies have shown that cannabis, along with natural neurotransmitters produced in the brain, can impair memory and reduce anxiety when the activate CB1 receptors in the brain.

The new study is the first to show, through brain imaging, that people with PTSD have remarkably lower concentrations of at least one of these endocannabinoids -- anandamide -- than people without PTSD.
The findings pave the way for development of the first-ever medication designed specifically to treat PTSD, something that researchers say is desperately needed.

"The first line of treatment (for PTSD patients) is selective serotonin re-uptake inhibitors, which is a class of medication generally used with good effects in people with depression," said Dr. Alexander Neumeister, lead author of the study and director of the molecular imaging program in the departments of psychiatry and radiology at NYU School of Medicine.

"These medications do not really do the job for people with PTSD, so clinicians use anything else that is legally available on the market," Dr. Neumeister said. "They often use different classes of medications developed for things like depression, schizophrenia, or bipolar disorder, and overall there's a consensus that these do not work."

"There's not a single pharmacological treatment out there that has been developed specifically for PTSD," Dr. Neumeister said. "That's a problem.

"In fact, we know very well that people with PTSD who use marijuana -- a potent cannabinoid -- often experience more relief from their symptoms than they do from antidepressants and other psychiatric medications," Dr. Neumeister said. "Clearly, there's a very urgent need to develop novel evidence-based treatments for PTSD."

"About eight years ago, the first animal study was published showing that everybody has endogenous cannabinoids, or endocannabinoids, in the brain -- meaning this substance is in the brain of every person," Dr. Neumeister said. "Animal studies have suggested that increasing cannabinoids in the brain helps them to forget painful events and form new memories, so they start to learn to digest what they went through and get over it. We thought this may be relevant to PTSD."

The study divided 60 participants into three groups: those with PTSD; those with a history of trauma but no PTSD; and those with no history or either trauma or PTSD. Participants in all three groups received a radioactive tracer that illuminates CB1 receptors when exposed to PET scans.

Results showed that participants with PTSD, especially women, had more CB1 receptors in brain regions associated with fear and anxiety than volunteers without PTSD. The PTSD group also had less of the neurotransmitter anandamide, an endocannabinoid that binds to the CB1 receptor.

When anandamide levels are low, Dr. Neumeister explained, the brain compensates by increasing the number of CB1 receptors. "This helps the brain utilize the remaining endocannabinoids," he said.

"What is PTSD? It's an illness where people cannot forget what they have experienced," Dr. Neumeister said. "Our findings offer a possible explanation for this phenomenon."

Biological markers of PTSD -- such as these tests for CB1 receptors and anandamide levels -- could dramatically improve diagnosis and treatment for trauma victims, especially since current diagnostics for PTSD rely on subjective measures and patient recall, making it difficult to accurately diagnose the condition or distinguish it from depression and anxiety.

An estimated 20 percent of the 1.7 million men and women who have served in the wars in Iraq and Afghanistan have PTSD, but it is not limited to soldiers. Trauma from sexual and physical abuse, car accidents, natural disasters, and life-threatening medical diagnoses can lead to PTSD; it affects nearly 8 million Americans annually.

"We want to increase the concentration of these endocannabinoids," Dr. Neumeister said. "So we are currently working on the methods to do this, and we have developed a compound that is able to increase the concentration of endocannabinoids without attacking the receptors."

The thing is, we already have a safe, natural and organic way to increase the concentration of cannabinoids in the brain -- it's called smoking pot, and you don't have to pay a big pharmaceutical corporation to do so, at least yet, anyway.
But Neumeister said the compound he's investigating is "very safe" and does not come with the "added health problems" of marijuana use. Without detailing what "health problems" those would those be, exactly (studies have shown that not only does marijuana not harm the lungs or pulmonary system; it actually appears to increase lung health.)

 

SOURCE: steveelliott's blog and Hemp.org

 

Brain injury, PTSD & Epilepsy

Brain injury, PTSD, Epilepsy and Medical Marijuana

 by: Debbie Wilson

Dear friends if you have a brain injury, PTSD, depression, post traumatic headaches or lack the feeling of overall well being like I did for over two decades please read further.

If you are NOT improving you may have to take things beyond conventional medicine and the comfort of your doctors knowledge base. I was fortunate and both my neurologist and primary care doctors have documented my cannabis trial in my medical records. They were an integral part of this medical cannabis journey.

I was honest with my doctors and this is what I found.

Most doctors are relieved when a chronic patient gets some relief even in an illegal state if you document and then take the documents to them! My first primary care doctor was married to an attorney and he would NOT document the truth so I changed primary care doctors!

I learned the hard way to question my doctors!

Please learn from my personal loss of organs from mega doses of medication! It is not the easiest way. I had no idea what a political arena I would end up in.

I am a medically retired felony probation and parole officer, I never saw how medical cannabis could help me until three years ago. We may only be in a small percentage but it is time to have a voice for neurology patients! We count also!

Our medicine also needs to be legal, accessible and affordable, GLOBALLY! Visit me and learn the science behind the medical cannabis component cannabidiol (CBD) and the brain!

Debbie Wilson
Neurology and CBD
 https://www.facebook.com/neurologyandcbd?ref=tn_tnmn

 

Source: By Debbie Wilson  on January 22, 2013| From noahsarkconsulting.blogspot.com